1. Structural Exploration of Hydroxyethylamines as HIV-1 Protease Inhibitors: New Features Identified. Amin, S.A., N. Adhikari, S. Bhargava, T. Jha, and S. Gayen. SAR and QSAR in Environmental Research, 2018. 29(5): p. 385-408. PMID[29566580].
[PubMed]. HIV_05_2018.
2. Synthesis, Characterization and Biological Activities of New Symmetric bis-1,2,3-Triazoles with Click Chemistry. Celik, F., Y. Unver, B. Barut, A. Ozel, and K. Sancak. Medicinal Chemistry, 2018. 14(3): p. 230-241. PMID[29165092].
[PubMed]. HIV_05_2018.
3. The Design, Synthesis and Structure-Activity Relationships Associated with C28 Amine-based Betulinic acid Derivatives as Inhibitors of HIV-1 Maturation. Chen, Y., S.Y. Sit, J. Chen, J.J. Swidorski, Z. Liu, N. Sin, B.L. Venables, D.D. Parker, B. Nowicka-Sans, Z. Lin, Z. Li, B.J. Terry, T. Protack, S. Rahematpura, U. Hanumegowda, S. Jenkins, M. Krystal, I.D. Dicker, N.A. Meanwell, and A. Regueiro-Ren. Bioorganic & Medicinal Chemistry Letters, 2018. 28(9): p. 1550-1557. PMID[29631960].
[PubMed]. HIV_05_2018.
4. Broadly Neutralizing anti-HIV-1 Antibodies Do Not Inhibit HIV-1-env-mediated Cell-Cell Fusion. Duzgunes, N., M. Yee, and D. Chau. Biophysical Journal, 2018. 114(3): p. 603A-604A. ISI[000430563300018].
[WOS]. HIV_05_2018.
5. 1,2,3,4-Tetrahydroisoquinolines as Inhibitors of HIV-1 Integrase and Human LEDGF/p75 Interaction. George, A., A.G.K. Reddy, G. Satyanarayana, and N.K. Raghavendra. Chemical Biology & Drug Design, 2018. 91(6): p. 1133-1140. PMID[29405651].
[PubMed]. HIV_05_2018.
6. Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure-Activity Studies, Biological and X-ray Structural Analysis. Ghosh, A.K., R.N. P, S. Kovela, K.V. Rao, M. Brindisi, H.L. Osswald, M. Amano, M. Aoki, J. Agniswamy, Y.F. Wang, I.T. Weber, and H. Mitsuya. Journal of Medicinal Chemistry, 2018. 61(10): p. 4561-4577. PMID[29763303].
[PubMed]. HIV_05_2018.
7. Anionic Carbosilane Dendrimers Destabilize the gp120-CD4 Complex Blocking HIV-1 Entry and Cell to Cell Fusion. Guerrero-Beltran, C., I. Rodriguez-Izquierdo, M.J. Serramia, I. Araya-Duran, V. Marquez-Miranda, R. Gomez, F.J. de la Mata, M. Leal, F. Gonzalez-Nilo, and M.A. Munoz-Fernandez. Bioconjugate Chemistry, 2018. 29(5): p. 1584-1594. PMID[29570280].
[PubMed]. HIV_05_2018.
8. 14-Formyl-15-aryloxy/methoxymatrine and 14-Aryloxymethylidenyl-matrine Derivatives as anti-HIV-1 Agents. Huang, J.L., S.Y. Xiang, M. Lv, L.M. Yang, Y.Y. Zhang, Y.T. Zheng, and H. Xu. Medicinal Chemistry, 2018. 14(3): p. 249-252. PMID[28969577].
[PubMed]. HIV_05_2018.
9. Discovery of Novel Diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the "NNRTI Adjacent" Binding Site. Huo, Z.P., H. Zhang, D.W. Kang, Z.X. Zhou, G.C. Wu, S. Desta, X.F. Zuo, Z. Wang, L.L. Jing, X. Ding, D. Daelemans, C.E. De, C. Pannecouque, P. Zhan, and X.Y. Liu. ACS Medicinal Chemistry Letters, 2018. 9(4): p. 334-338. PMID[29670696]. PMCID[PMC5900322].
[PubMed]. HIV_05_2018.
10. Further Exploring Solvent-exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery. Kang, D.W., Z. Wang, H. Zhang, G.C. Wu, T. Zhao, Z.X. Zhou, Z.P. Huo, B.S. Huang, D. Feng, X. Ding, J. Zhang, X.F. Zuo, L.L. Jing, W. Luo, S. Guma, D. Daelemans, C.E. De, C. Pannecouque, P. Zhan, and X.Y. Liu. ACS Medicinal Chemistry Letters, 2018. 9(4): p. 370-375. PMID[29670703]. PMCID[PMC5900328].
[PubMed]. HIV_05_2018.
11. Design and Synthesis of Novel 1,2,3-Triazolyl-pyrimidinone Hybrids as Potential anti-HIV-1 NNRT Inhibitors. Kasralikar, H.M., S.C. Jadhavar, S.G. Bhansali, S.B. Patwari, and S.R. Bhusare. Journal of Heterocyclic Chemistry, 2018. 55(4): p. 821-829. ISI[000430179800004].
[WOS]. HIV_05_2018.
12. Characterization of a Sulfated anti-HIV Antibody Using an Expanded Genetic Code. Li, X., J. Hitomi, and C.C. Liu. Biochemistry, 2018. 57(20): p. 2903-2907. PMID[29738662].
[PubMed]. HIV_05_2018.
13. TLR7 Agonists Induce Transient Viremia and Reduce the Viral Reservoir in SIV-infected Rhesus Macaques on Antiretroviral Therapy. Lim, S.Y., C.E. Osuna, P.T. Hraber, J. Hesselgesser, J.M. Gerold, T.L. Barnes, S. Sanisetty, M.S. Seaman, M.G. Lewis, R. Geleziunas, M.D. Miller, T. Cihlar, W.A. Lee, A.L. Hill, and J.B. Whitney. Science Translational Medicine, 2018. 10(439): eaao4521. PMID[29720451]. PMCID[PMC5973480].
[PubMed]. HIV_05_2018.
14. HIV-1 Infection of Microglial Cells in a Reconstituted Humanized Mouse Model and Identification of Compounds that Selectively Reverse HIV Latency. Llewellyn, G.N., D. Alvarez-Carbonell, M. Chateau, J. Karn, and P.M. Cannon. Journal of Neurovirology, 2018. 24(2): p. 192-203. PMID[29256041]. PMCID[PMC5910454].
[PubMed]. HIV_05_2018.
15. Identification of Small Molecule Compounds Targeting the Interaction of HIV-1 Vif and Human APOBEC3G by Virtual Screening and Biological Evaluation. Ma, L., Z. Zhang, Z. Liu, Q. Pan, J. Wang, X. Li, F. Guo, C. Liang, L. Hu, J. Zhou, and S. Cen. Scientific Reports, 2018. 8(8067): 12pp. PMID[29795228]. PMCID[PMC5966509].
[PubMed]. HIV_05_2018.
16. Design, Synthesis, and anti-HIV-1 Evaluation of a Novel Series of 1,2,3,4-Tetrahydropyrimidine-5-carboxylic acid Derivatives. Sepehri, S., S. Soleymani, R. Zabihollahi, M.R. Aghasadeghi, M. Sadat, L. Saghaie, H.R. Memarian, and A. Fassihi. Chemistry & Biodiversity, 2018. 15(4): p. e1700502. PMID[29411517].
[PubMed]. HIV_05_2018.
17. Ranpirnase: A Potential Microbicide with Broad-spectrum Antiviral Profile (HIV, HSV, HPV). Squiquera, L., T. Hodge, J. Sulley, and D. Sidransky. Journal of Investigative Dermatology, 2018. 138(5): p. S79-S79. ISI[000431188500466].
[WOS]. HIV_05_2018.
18. Targeting the Entrance Channel of NNIBP: Discovery of Diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as Novel HIV-1 NNRTIs with High Potency against Wild-type and E138K Mutant Virus. Tian, Y., Z. Liu, J. Liu, B. Huang, D. Kang, H. Zhang, E. De Clercq, D. Daelemans, C. Pannecouque, K.H. Lee, C.H. Chen, P. Zhan, and X. Liu. European Journal of Medicinal Chemistry, 2018. 151: p. 339-350. PMID[29635166].
[PubMed]. HIV_05_2018.
19. Improvement of the Activity of the anti-HIV-1 Integrase Aptamer T30175 by Introducing a Modified Thymidine into the Loops. Virgilio, A., T. Amato, L. Petraccone, F. Esposito, N. Grandi, E. Tramontano, R. Romero, S. Haider, I. Gomez-Monterrey, E. Novellino, L. Mayol, V. Esposito, and A. Galeone. Scientific Reports, 2018. 8(7447): 9pp. PMID[29749406]. PMCID[PMC5945619].
[PubMed]. HIV_05_2018.
20. Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate. Wang, X., J. Wang, W. Zhang, B. Li, Y. Zhu, Q. Hu, Y. Yang, X. Zhang, H. Yan, and Y. Zeng. Viruses, 2018. 10(265): 15pp. PMID[29772712]. PMCID[PMC5977258].
[PubMed]. HIV_05_2018.
21. A CCR5 Antagonist-based HIV Entry Inhibitor Exhibited Potent Spermicidal Activity: Potential Application for Contraception and Prevention of HIV Sexual Transmission. Yang, M.J., R.N. Zhi, L. Lu, M.X. Dong, Y.Z. Wang, F. Tian, M.J. Xia, J.Y. Hu, Q.Y. Dai, S.B. Jiang, and W.H. Li. European Journal of Pharmaceutical Sciences, 2018. 117: p. 313-320. PMID[29496533].
[PubMed]. HIV_05_2018.
Patent Citations
22. Therapeutic Composition Derived from Anthostema senegalense. Balde, A.M. Patent. 2018. 2017-FR52891 2018073551: 43pp ; Chemical Indexing Equivalent to 168:472250 (FR).
[Patent]. HIV_05_2018.
23. Compositions and Methods for Treating HIV-1 Latency. Barnes, A.B., G. Kyei, and B. Albert. Patent. 2018. 2017-US60791 2018089592: 62pp.
[Patent]. HIV_05_2018.
24. Preparation of Aryl-Amide phosphodiamide Compounds as Antiviral Prodrugs for the Treatment of HIV and AIDS. Paparin, J.-L., H. Rahali, A. Salanson, D. Da Costa, D. Dukhan, T.J. Hartingh, I. Raheem, and J. Schreier. Patent. 2018. 2017-US57490 2018080903: 62pp.
[Patent]. HIV_05_2018.